project id: TCGA-LUAD; case submitter id: TCGA-97-A4M6; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; age at index: 45; days to birth: -16764; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1967; age at diagnosis: 16764; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IA; ajcc pathologic t: T1a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 568.0; icd 10 code: C34.3; last known disease status: not reported; morphology: 8255/3; primary diagnosis: Adenocarcinoma with mixed subtypes; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower lobe, lung; synchronous malignancy: No; tissue or organ of origin: Lower lobe, lung; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 115; days to sample procurement: 0; initial weight: 180.0; portion submitter id: TCGA-97-A4M6-01A-11; percent lymphocyte infiltration: 6.0; percent monocyte infiltration: 4.0; percent necrosis: 4.0; percent neutrophil infiltration: 1.0; percent normal cells: 33.0; percent stromal cells: 22.0; percent tumor cells: 41.0; percent tumor nuclei: 75.0;